Pharma Tips

Biocon net profit falls 13% to Rs 91 cr; to offload 10-15% in Syngene

By: Pharma News | Views: 746 | Date: 11-Feb-2015

Biotech firm Biocon on Thursday reported a 13 per cent fall in net profit for October-December quarter at Rs 91 crore and said it will sell 10-15 per cent stake in its research services arm Syngene.

Biocon net profit falls 13% to Rs 91 cr; to offload 10-15% in Syngene

Biotech firm Biocon on Thursday reported a 13 per cent fall in net profit for October-December quarter at Rs 91 crore and said it will sell 10-15 per cent stake in its research services arm Syngene.

The company had clocked Rs 105 crore net profit in the corresponding quarter of the last fiscal.

Revenues stood at Rs 779 crore, up 8 per cent over the corresponding quarter last fiscal.

Bio-pharmaceuticals contributed Rs 541 crore and research services Rs 220 crore to revenue for the reporting quarter.

Other income contributed the remaining, it said in a release.

While approving listing of Syngene through offer for sale route, Biocon Board has also gave approval to initiate the process of appointing merchant bankers. The company would offload 10-15 per cent stake from present holding of 85.54 per cent.

"The timing of listing of Syngene on the Indian stock exchanges will be dependent on regulatory approvals and market conditions," the company said.

Biocon, through its wholly owned subsidiary Biocon Research, had sold 10 per cent stake in Syngene International (Syngene) earlier this month.

"Biocon continues to invest in its uniquely differentiated Biosimilars portfolio, which straddles both Insulins and Monoclonal Antibodies. We are confident this will deliver short term growth in the emerging markets and drive long term value creation across global markets," said company Chairman and Managing Director Kiran Mazumdar-Shaw.

The company also inducted former TEVA CEO Jeremy M Levin and Harvard Medical School Professor Vijay K Kuchroo, as the additional independent directors on its Board.

Previous Page Next Page

People Searching On This Page:

Related Pages


Mankind Pharma Investing Rs 100 cr API Facility in Rajasthan

Mankind Pharma Investing Rs 100 cr API Facility in Rajasthan

News | Pharma Companies
Date:
18-Apr-2015  Views: 3169

Mankind Pharma is investing around Rs 100 crore to set up an active pharmaceutical ingredients (API) facility in Rajasthan, which is expected to go on ...
Cipla posts 15 percent rise in Q3 profit

Cipla posts 15 percent rise in Q3 profit

News | Pharma Companies
Date:
26-Feb-2015  Views: 1813

Cipla, the pharmaceutical firm, on Thursday reported 15.31 per cent increase in its consolidated net profit at Rs 327.85 crore in the third quarter e ...
Dr Reddy's net profit falls 7.09% in Q3

Dr Reddy's net profit falls 7.09% in Q3

News | Pharma Companies
Date:
05-Feb-2015  Views: 676

Drug major Dr Reddy's Laboratories on Thursday reported a 7.09 per cent decline in its consolidated net profit at Rs 574.53 crore for the quarter ende ...
Sun Pharma Q4 net profit up 57 percent, beats expectations

Sun Pharma Q4 net profit up 57 percent, beats expectations

News | Pharma Companies
Date:
22-Jul-2014  Views: 1292

Sun Pharmaceutical Industries, India's third-largest drugmaker by revenue, has reported a 57 per cent jump in fourth-quarter net profit, slightly abov ...
Walk in recritement of RSM, ASM and MRs at Overseas Healthcare

Walk in recritement of RSM, ASM and MRs at Overseas Healthcare

Jobs
Date:
12-Jul-2010  Views: 1790

Candidate should be science/pharmacy graduate with relevent experience. Freshers with good communication skills may also apply. ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

55  + 8 =     
Comments

Google : 52 times | Yahoo : 13 times | Bing : 1 times |